| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-03-08 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 29,630 | $11.47 | $339,756.65 | -0.5% | → |
| 2022-03-07 | BALDO LANCE | Chief Medical Officer | Sell | 2,373 | $12.01 | $28,499.73 | -10.4% | → |
| 2022-03-07 | RUBINSTEIN JULIE | President | Sell | 4,613 | $12.01 | $55,402.13 | -2.0% | → |
| 2022-03-07 | ADAMS R MARK | Chief Operating Officer | Sell | 1,244 | $12.01 | $14,940.44 | -1.0% | → |
| 2022-03-07 | BENZENO SHARON | Chief Business Development Off | Sell | 2,670 | $12.01 | $32,066.70 | -2.5% | → |
| 2022-03-07 | ROBINS CHAD M | CEO and Chairman | Sell | 4,424 | $12.01 | $53,132.24 | -0.2% | → |
| 2022-03-07 | ROBINS HARLAN S | Chief Scientific Officer | Sell | 4,517 | $12.01 | $54,249.17 | -1.4% | → |
| 2022-03-07 | LO FRANCIS | Chief People Officer | Sell | 1,569 | $12.01 | $18,843.69 | -1.7% | → |
| 2022-03-07 | PISKEL KYLE | Principal Accounting Officer | Sell | 220 | $12.01 | $2,642.20 | -0.5% | → |
| 2022-03-07 | Taylor Stacy L | SVP and General Counsel | Sell | 1,569 | $12.01 | $18,843.69 | -2.0% | → |
| 2022-01-07 | ADAMS R MARK | Chief Operating Officer | Sell | 1,021 | $23.32 | $23,809.72 | -2.0% | → |
| 2021-12-22 | Cohen Chad M | Chief Financial Officer | Sale+OE | 10,000 | $30.00 | $300,000.00 | -31.6% | → |
| 2021-12-22 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 15,338 | $30.00 | $460,140.00 | -50.5% | → |
| 2021-11-18 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 4,000 | $32.00 | $127,993.00 | -2.8% | → |
| 2021-11-10 | Cohen Chad M | Chief Financial Officer | Sale+OE | 10,000 | $34.98 | $349,800.00 | -18.8% | → |
| 2021-10-21 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 11,200 | $33.71 | $377,561.00 | -3.8% | → |
| 2021-10-08 | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $33.16 | $103,629.95 | -2.9% | → |
| 2021-10-08 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 11,685 | $32.95 | $385,018.45 | -4.0% | → |
| 2021-10-06 | Cohen Chad M | Chief Financial Officer | Sale+OE | 10,000 | $32.41 | $324,050.00 | -18.8% | → |
| 2021-09-15 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 11,685 | $36.98 | $432,054.00 | -2.7% | → |
| 2021-09-10 | ROBINS CHAD M | CEO and Chairman | Sell | 43,499 | $38.43 | $1,671,495.54 | -0.5% | → |
| 2021-09-08 | Cohen Chad M | Chief Financial Officer | Sale+OE | 14,375 | $39.47 | $567,331.25 | -25.0% | → |
| 2021-09-07 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 495 | $40.00 | $19,800.00 | -3.2% | → |
| 2021-08-27 | GRIFFIN MICHELLE RENEE | Director | Sale+OE | 14,916 | $35.00 | $522,060.00 | -90.8% | → |
| 2021-08-27 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 11,685 | $34.25 | $400,231.06 | -4.0% | → |